$MAMA

MamaMancini's Holdings, Inc.

CIK:0001520358|SEC Filings

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2026	Jul. 31, 2025	Jul. 31, 2026	Jul. 31, 2025
Income Statement [Abstract]
Net sales	$ 54,582	$ 35,203	$ 107,348	$ 70,458
Costs of sales	41,505	26,432	81,844	52,503
Gross profit	13,077	8,771	25,504	17,955
Operating expenses:
Research and development	94	55	181	128
Selling, general and administrative expenses	9,991	7,016	19,667	14,549
Total operating expenses	10,085	7,071	19,848	14,677
Income from operations	2,992	1,700	5,656	3,278
Other income (expenses)
Interest expense	(100)	(77)	(209)	(165)
Interest income	424	25	514	55
Amortization of debt discount	(12)	(3)	(23)	(6)
Total other income (expenses)	312	(55)	282	(116)
Net income before income tax provision	3,304	1,645	5,938	3,162
Income tax expense	(739)	(368)	(1,316)	(648)
Net income	$ 2,565	$ 1,277	$ 4,622	$ 2,514
Net income per common share
basic (in dollars per share)	$ 0.06	$ 0.03	$ 0.11	$ 0.07
diluted (in dollars per share)	$ 0.06	$ 0.03	$ 0.10	$ 0.06
Weighted average common shares outstanding
basic (in shares)	42,736	37,687	41,717	37,643
diluted (in shares)	45,319	39,744	44,334	39,708

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2026	Jul. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 4,622	$ 2,514
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	2,340	1,137
Amortization of debt discount	23	6
Amortization of right of use assets	885	589
Amortization of intangibles	869	751
Stock-based compensation	1,454	640
Change in deferred tax asset	(232)	(258)
Changes in operating assets and liabilities, net of acquisition:
Accounts receivable	186	1,391
Inventories	(1,015)	(1,616)
Prepaid expenses and other current assets	760	625
Accounts payable and accrued expenses	2,830	(925)
Operating lease liability	(826)	(520)
Net Cash Provided by Operating Activities	11,896	4,334
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of fixed assets	(1,089)	(1,053)
Net Cash Used in Investing Activities	(1,089)	(1,053)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayment of debt	(589)	(891)
Net proceeds from issuance of common stock	108,557	0
Repayment of finance lease obligations	(157)	(193)
Proceeds from exercise of stock options	48	37
Net Cash Provided by (Used in) Financing Activities	107,859	(1,047)
Net Increase in Cash	118,666	2,234
Cash and cash equivalents at beginning of period	19,951	7,150
Cash and cash equivalents at end of period	138,617	9,384
SUPPLEMENTARY CASH FLOW INFORMATION:
Income taxes	858	659
Interest	208	152
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Right-of-use asset and lease liability recognized	0	4,156
Payment of related party debt	0	1,500
Write-off of right-of-use asset	0	451
Issuance of common stock for employee compensation	105	0
Receipt of fixed assets for deposits previously paid	$ 0	$ 74

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 31, 2026	Jan. 31, 2026
Current Assets:
Cash and cash equivalents	$ 138,617	$ 19,951
Accounts receivable, net	12,886	13,072
Inventories, net	10,662	9,647
Prepaid expenses and other current assets	1,651	2,411
Total Current Assets	163,816	45,081
Property, plant, and equipment, net	18,857	20,108
Intangible assets, net	2,221	3,090
Goodwill	9,447	9,447
Operating lease right of use assets, net	6,992	7,877
Deposits	95	95
Total Assets	201,428	85,698
Current Liabilities:
Accounts payable and accrued expenses	20,525	17,800
Term loan, net of unamortized debt discount of $193 and $216, respectively	983	960
Operating lease liabilities	1,796	1,690
Finance leases payable	333	321
Total Current Liabilities	23,637	20,771
Term loan – net of current	3,823	4,412
Operating lease liabilities – net of current	5,272	6,204
Deferred tax liability	581	813
Finance leases payable – net of current	709	878
Total long-term liabilities	10,385	12,307
Total Liabilities	34,022	33,078
Commitments and contingencies (Notes 10 and 11)
Stockholders’ Equity:
Common stock, $0.00001 par value; 250,000,000 shares authorized; 47,375,000 and 40,887,000 shares issued as of July 31, and January 31, 2026, respectively, 47,145,000 and 40,657,000 shares outstanding as of July 31, and January 31, 2026, respectively	0	0
Additional paid-in capital	157,484	47,320
Retained earnings	10,072	5,450
Less: Treasury stock, 230,000 shares at cost	(150)	(150)
Total Stockholders’ Equity	167,406	52,620
Total Liabilities and Stockholders’ Equity	201,428	85,698
Series A Preferred Stock
Stockholders’ Equity:
Preferred stock value	0	0
Series B Preferred Stock
Stockholders’ Equity:
Preferred stock value	0	0
Preferred Stock
Stockholders’ Equity:
Preferred stock value	$ 0	$ 0